On May 2, 2023, Nicole Steinmetz, Ph.D., advised the board of directors of Mosaic ImmunoEngineering, Inc. of her intention to resign as a member of the board of directors and acting Chief Scientific Officer effective immediately. Dr. Steinmetz confirmed to the Company's board of directors that her resignation is not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Dr. Steinmetz will remain engaged with the Company as a scientific advisor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3131 USD | +0.03% | -22.11% | -47.82% |
Apr. 15 | Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Mosaic ImmunoEngineering, Inc. Receives Letter of Termination from CWRU | CI |
1st Jan change | Capi. | |
---|---|---|
-47.82% | 2.27M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CPMV Stock
- News Mosaic ImmunoEngineering, Inc.
- Mosaic Immunoengineering, Inc. Announces Nicole Steinmetz, Ph.D., to Resign as A Member of the Board of Directors and Acting Chief Scientific Officer